These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients. Gupta DG; Varma N; Naseem S; Sachdeva MUS; Bose P; Binota J; Kumar A; Gupta M; Rana P; Sonam P; Malhotra P; Trehan A; Khadwal A; Varma S Turk J Haematol; 2022 Feb; 39(1):1-12. PubMed ID: 34617433 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature. Shafer D; Wu H; Al-Saleem T; Reddy K; Borghaei H; Lessin S; Smith M Arch Dermatol; 2008 Sep; 144(9):1155-62. PubMed ID: 18794461 [TBL] [Abstract][Full Text] [Related]
8. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia. Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541 [TBL] [Abstract][Full Text] [Related]
9. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan. Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914 [TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of human B cell precursor-leukemia cell lines. Matsuo Y; Drexler HG Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106 [TBL] [Abstract][Full Text] [Related]
11. Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis. Traxel S; Lehmann J; Richard S; Sidorov S; Niggli F; Berger C; Nadal D; Bürgler S Cancer Immunol Immunother; 2021 Aug; 70(8):2275-2289. PubMed ID: 33507341 [TBL] [Abstract][Full Text] [Related]
12. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia. Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia. James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353 [TBL] [Abstract][Full Text] [Related]
17. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia. Sędek Ł; Theunissen P; Sobral da Costa E; van der Sluijs-Gelling A; Mejstrikova E; Gaipa G; Sonsala A; Twardoch M; Oliveira E; Novakova M; Buracchi C; van Dongen JJM; Orfao A; van der Velden VHJ; Szczepański T; J Immunol Methods; 2019 Dec; 475():112429. PubMed ID: 29530508 [TBL] [Abstract][Full Text] [Related]
19. CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia. Gudapati P; Khanka T; Chatterjee G; Ghogale S; Badrinath Y; Deshpande N; Patil J; Narula G; Shetty D; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR Cytometry B Clin Cytom; 2020 Jul; 98(4):328-335. PubMed ID: 31944572 [TBL] [Abstract][Full Text] [Related]
20. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma. Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]